.PfizerCustom Drug Product Sales Sr. Manager in Collegeville, BotPfizerSenior Manager, DevSecOps Engineering in Collegeville, BotPfizerVice President, Oncology Breast Therapeutic Area Medical Head, MD in New York City, BotFeatured EmployersDirector, Patient Advocacy & External PartnershipsCompany: PfizerLocation:, BotEmployment Type: Full TimeDate Posted: 05/03/2024Job Categories: Biotechnology and Pharmaceutical, Government and Policy, Healthcare, Other, Healthcare, Practitioner and Technician, Legal, Manufacturing and Production, Sales, Science, Quality Control, Research & Development, Medical, Writing/Authoring, Energy / UtilitiesJob DescriptionDirector, Patient Advocacy & External Partnerships**ROLE SUMMARY****The Platform:** The Chief Medical Affairs Office's Real World Evidence (RWE) Platform is responsible for establishing global scientific leadership and stature as well as building public & patient trust through the generation of integrated, end-to-end observational real-world evidence serving all therapeutic areas from proof of concept (POC) trials through LOE for priority pipeline candidates, pipeline supplementation through business development, and marketed inline products. The Platform fully centralizes RWE, epidemiology, outcomes research, RW-relevant health informatics, and biostatistics talent from global, international markets into one team to drive efficiency through internalized work.The Platform functions to:enhance Pfizer's ability to determine unmet medical needs; support differentiated product labels for Product Development programs including finding alternatives and accelerated licensure pathways for new indications through the use of Real World Data (RWD), Real World Insights (RWI) and RWE; inform clinical practice on appropriate prescription and use of Pfizer's products; in collaboration with Access & Value, strengthen the value evidence package for payers and access/policy decision-makers; support measurement of short- and long-term impact of Pfizer's products to both patients and populations; support competitive differentiation.RWE, other patient-centric evidence, and RWI will be generated by the Platform for all global, prioritized IDM and prioritized EM needs through a combinatorial approach of cutting edge retrospective data analyses, site-based evaluations (e.G., Phase IV observational effectiveness studies, burden of illness, transmission, pathogenesis, risk factors for illness, determinants of product effectiveness and other studies), application of novel methods and technologies, and supplementation of interventional trials where appropriate with RWE through hybrid trial designs and tokenization.**The opportunity:** Reporting to the Head of Patient Advocacy & External Partnerships, this role is critical for the RWE Platform to ensure that the voice of the patient is at the center of our work
